132 related articles for article (PubMed ID: 15259917)
1. Determination of physicochemical properties of halofantrine.
Babalola CP; Adegoke AO; Ogunjinmi MA; Osimosu MO
Afr J Med Med Sci; 2003 Dec; 32(4):357-9. PubMed ID: 15259917
[TBL] [Abstract][Full Text] [Related]
2. A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs.
Khoo SM; Prankerd RJ; Edwards GA; Porter CJ; Charman WN
J Pharm Sci; 2002 Mar; 91(3):647-59. PubMed ID: 11920750
[TBL] [Abstract][Full Text] [Related]
3. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine.
Humberstone AJ; Porter CJ; Charman WN
J Pharm Sci; 1996 May; 85(5):525-9. PubMed ID: 8742945
[TBL] [Abstract][Full Text] [Related]
4. Determination of the physicochemical properties of pyronaridine - a new antimalarial drug.
Adegoke OA; Babalola CP; Oshitade OS; Famuyiwa AA
Pak J Pharm Sci; 2006 Jan; 19(1):1-6. PubMed ID: 16632444
[TBL] [Abstract][Full Text] [Related]
5. Experimental determination of the physicochemical properties of lumefantrine.
Kotila OA; Olaniyi OO; Adegoke AO; Babalola CP
Afr J Med Med Sci; 2013 Sep; 42(3):209-14. PubMed ID: 24579381
[TBL] [Abstract][Full Text] [Related]
6. Partitioning of halofantrine hydrochloride between water, micellar solutions, and soybean oil: Effects on its apparent ionization constant.
Taillardat-Bertschinger A; Perry CS; Galland A; Prankerd RJ; Charman WN
J Pharm Sci; 2003 Nov; 92(11):2217-28. PubMed ID: 14603507
[TBL] [Abstract][Full Text] [Related]
7. Caffeine and nicotinamide enhances the aqueous solubility of the antimalarial agent halofantrine.
Lim LY; Go ML
Eur J Pharm Sci; 2000 Mar; 10(1):17-28. PubMed ID: 10699380
[TBL] [Abstract][Full Text] [Related]
8. [Identity and physicochemical properties of 1-(4-chlorophenyl)-4-morpholino-imidazolin-2-one, AWD 131-138].
Heinecke K; Thiel W
Pharmazie; 2001 Jun; 56(6):458-61. PubMed ID: 11446164
[TBL] [Abstract][Full Text] [Related]
9. Halofantrine-phospholipid interactions: monolayer studies.
Go ML; Feng SS
Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):871-6. PubMed ID: 11456094
[TBL] [Abstract][Full Text] [Related]
10. Structure of the antimalarial halofantrine hydrochloride.
Karle JM; Karle IL
Acta Crystallogr C; 1989 Aug; 45 ( Pt 8)():1248-50. PubMed ID: 2604946
[TBL] [Abstract][Full Text] [Related]
11. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
12. Comparative determination of halofantrine tablets by titrimetry, spectrophotometry and liquid chromatography.
Kolade YT; Adegbolagun OM; Idowu OS; Bahalola CP; Olaniyi AA
Afr J Med Med Sci; 2006 Mar; 35(1):79-84. PubMed ID: 17209332
[TBL] [Abstract][Full Text] [Related]
13. Estimation of selected physicochemical properties for methylated naphthalene compounds.
Dimitriou-Christidis P; Harris BC; McDonald TJ; Reese E; Autenrieth RL
Chemosphere; 2003 Aug; 52(5):869-81. PubMed ID: 12757788
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical profile of nimesulide. Exploring the interplay of lipophilicity, solubility and ionization.
Dellis D; Giaginis C; Tsantili-Kakoulidou A
J Pharm Biomed Anal; 2007 May; 44(1):57-62. PubMed ID: 17336024
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro evaluation of solid dispersions of halofantrine.
Abdul-Fattah AM; Bhargava HN
Int J Pharm; 2002 Mar; 235(1-2):17-33. PubMed ID: 11879736
[TBL] [Abstract][Full Text] [Related]
16. X-ray crystal structure of the antimalarial agent (-)-halofantrine hydrochloride supports stereospecificity for cardiotoxicity.
Karle JM
Antimicrob Agents Chemother; 1997 Apr; 41(4):791-4. PubMed ID: 9087491
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the antimalarial drug halofantrine and its major metabolite N-desbutylhalofantrine in human plasma by high performance liquid chromatography.
Kolade YT; Babalola CP; Scriba GK
J Pharm Biomed Anal; 2006 Apr; 41(1):315-9. PubMed ID: 16337357
[TBL] [Abstract][Full Text] [Related]
18. Prediction of oral absorption in humans by experimental immobilized artificial membrane chromatography indices and physicochemical descriptors.
Kotecha J; Shah S; Rathod I; Subbaiah G
Int J Pharm; 2008 Aug; 360(1-2):96-106. PubMed ID: 18524510
[TBL] [Abstract][Full Text] [Related]
19. Phenothiazines solution complexity - Determination of pKa and solubility-pH profiles exhibiting sub-micellar aggregation at 25 and 37°C.
Pobudkowska A; Ràfols C; Subirats X; Bosch E; Avdeef A
Eur J Pharm Sci; 2016 Oct; 93():163-76. PubMed ID: 27449396
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS).
Thomas N; Holm R; Müllertz A; Rades T
J Control Release; 2012 May; 160(1):25-32. PubMed ID: 22405903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
